Blog


Understanding State Laws for Interchangeable Biosimilars

October 15, 2021

An important development in the biopharmaceutical world, with significant ramifications for patients, is the progress being made on biosimilars.  These are products with the same safety and efficacy as FDA-approved … Continued


Lawmakers Have a Drug Pricing Solution Right in Front of Them

October 4, 2021

As Congress continues to deliberate on drug pricing proposals that many would call extreme, even radical – empowering the federal government to set prices instead of having prices negotiated in … Continued